T-cells in Alzheimer's disease
- PMID: 16247185
- DOI: 10.1385/NMM:7:3:255
T-cells in Alzheimer's disease
Abstract
Alzheimer's disease (AD) is the most common dementing illness and is pathologically characterized by deposition of the 40-42 amino acid peptide, amyloid-beta (Abeta), as senile plaques. It is well documented that brain inflammatory mechanisms mediated by reactive glia are activated in response to Abeta plaques. A number of reports further suggest that T-cells are activated in AD patients, and that these cells exist both in the periphery and as infiltrates in the brain. We explore the potential role of T-cells in the AD process, a controversial area, by reviewing reports that show disturbed activation profiles and/or altered numbers of various subsets of T-cells in the circulation as well as in the AD brain parenchyma and in cerebral amyloid angiopathy. We also discuss the recent Abeta immunotherapy approach vis-à-vis the activated, autoaggressive T-cell infiltrates that contributed to aseptic meningoencephalitis in a small percentage of patients, and present possible alternative approaches that may be both efficacious and safe. Finally, we explore the use of mouse models of AD as a system within which to definitively test the possible contribution of T-cells to AD pathogenesis.
Similar articles
-
T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer's disease-like cerebral amyloidosis.Brain Behav Immun. 2016 May;54:211-225. doi: 10.1016/j.bbi.2016.02.009. Epub 2016 Feb 9. Brain Behav Immun. 2016. PMID: 26872418
-
The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: therapeutic implications.Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):223-33. doi: 10.2174/1568007054038229. Curr Drug Targets CNS Neurol Disord. 2005. PMID: 15975026 Review.
-
IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.J Immunol. 2013 Mar 1;190(5):2241-51. doi: 10.4049/jimmunol.1200947. Epub 2013 Jan 30. J Immunol. 2013. PMID: 23365075
-
Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.Neurobiol Aging. 2015 Jan;36(1):111-22. doi: 10.1016/j.neurobiolaging.2014.06.029. Epub 2014 Jul 3. Neurobiol Aging. 2015. PMID: 25085784
-
Targeting the hematopoietic system for the treatment of Alzheimer's disease.Brain Behav Immun. 2011 Jun;25 Suppl 1:S71-9. doi: 10.1016/j.bbi.2010.12.018. Epub 2010 Dec 30. Brain Behav Immun. 2011. PMID: 21195165 Review.
Cited by
-
Blockade of α4 integrins reduces leukocyte-endothelial interactions in cerebral vessels and improves memory in a mouse model of Alzheimer's disease.Sci Rep. 2019 Aug 19;9(1):12055. doi: 10.1038/s41598-019-48538-x. Sci Rep. 2019. PMID: 31427644 Free PMC article.
-
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation.Mol Neurobiol. 2019 May;56(5):3295-3312. doi: 10.1007/s12035-018-1283-6. Epub 2018 Aug 17. Mol Neurobiol. 2019. PMID: 30117106 Free PMC article. Review.
-
Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration.Front Cell Neurosci. 2019 Feb 26;13:63. doi: 10.3389/fncel.2019.00063. eCollection 2019. Front Cell Neurosci. 2019. PMID: 30863284 Free PMC article. Review.
-
Microglial TNF-α-dependent elevation of MHC class I expression on brain endothelium induced by amyloid-beta promotes T cell transendothelial migration.Neurochem Res. 2013 Nov;38(11):2295-304. doi: 10.1007/s11064-013-1138-5. Epub 2013 Aug 29. Neurochem Res. 2013. PMID: 23990225
-
Neuroinflammation and brain functional disconnection in Alzheimer's disease.Front Aging Neurosci. 2013 Nov 25;5:81. doi: 10.3389/fnagi.2013.00081. eCollection 2013. Front Aging Neurosci. 2013. PMID: 24324435 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical